SCHEMBL4170612

SCHEMBL4170612

CCCCCC(=O)N(CCC[O])Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.56
HDAC1 Q13547 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
HDAC3 O15379 1/20 0.54
HDAC2 Q92769 1/20 0.54
NCOR2 Q9Y618 1/20 0.54
LTB4R2 Q9NPC1 3/20 0.54
NPC1 O15118 1/20 0.52
LMNA P02545 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CA12 O43570 3/20 0.51
CA1 P00915 3/20 0.51
CA2 P00918 3/20 0.51
CA4 P22748 2/20 0.51
ALDH1A1 P00352 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
REN P00797 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4163435 0.99 CNR2 (0.58) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4161736 0.99 CNR2 (0.58) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4155178 0.99 CNR2 (0.58) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4155334 0.96 HDAC6 (0.59) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4156966 0.93 LTB4R2 (0.54) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4168772 0.91 CNR2 (0.56) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4167794 0.91 CNR2 (0.56) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4165489 0.91 CNR2 (0.56) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL4165741 0.91 LTB4R2 (0.53) CNR2HDAC1HDAC6HDAC3HDAC2
SCHEMBL27357692 0.90 LTB4R2 (0.56) CNR2HDAC1HDAC6HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088438-A1 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS LABORATORIOS SALVAT, S.A. (ES) 2009-04-02 US disclosed
US-7423172-B2 Tyrosine derivatives as PPAR-γ-modulators LABORATORIOS SALVAT, S.A. (ES) 2008-09-09 US disclosed
US-20070276043-A1 Tyrosine Derivatives As Ppar-Gamma-Modulators LABORATORIES SALVAT, S.A. (ES) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088438-A1 NEW TYROSINE DERIVATIVES AS PPARy MODULATORS PPARG, PPARD, TYRO3 CNR2 109/4885HDAC1 1912/4885HDAC6 1947/4885
US-20070276043-A1 Tyrosine Derivatives As Ppar-Gamma-Modulators PPARG, PPARD, PPARA CNR2 92/4885HDAC1 1656/4885HDAC6 1966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.